TIAA CREF Trust’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
TIAA CREF Trust's AMGN Position: Q1 2017 in Review
TIAA CREF Trust reduced its Amgen (AMGN) stake by 10% in Q1 2017, selling an estimated $2.2M and leaving 116,558 shares worth $19.1M. The position accounts for 0.14% of the portfolio, ranked #62.
TIAA CREF Trust first reported a position in AMGN in Q2 2013 and has held it in 16 quarters since. The position peaked at $21.4M in Q3 2016. 1,600 funds tracked by Wall St. Rank hold AMGN as of Q1 2017.
- TIAA CREF Trust held 116,558 shares of Amgen worth $19.1M as of Q1 2017.
- TIAA CREF Trust sold 13,233 Amgen shares in Q1 2017, an estimated $2.2M.
- Amgen made up 0.14% of TIAA CREF Trust's portfolio in Q1 2017, its #62 holding.
- TIAA CREF Trust first reported a position in Amgen in Q2 2013 and has held it in 16 quarters since.
- TIAA CREF Trust's Amgen position peaked at $21.4M in Q3 2016.
- 1,600 funds tracked by Wall St. Rank held Amgen as of Q1 2017.
Based on TIAA CREF Trust's 13F filing for Q1 2017, filed 3 May 2017.